Boundless Bio, Inc. · NASDAQ:BOLD
Tang Kevin bought 149,474 Boundless Bio, Inc. shares (Form 4)
Traded Oct 16 to Oct 20, 2026 · Filed Oct 20, 2026
From Oct 16 to Oct 20, 2026, Tang Kevin (10% owner) bought 149,474 Boundless Bio, Inc. shares at an average US$2.34 for US$350K, leaving 2,990,109 shares. Filed Oct 20, 2026 (Form 4).
- Bought
- 149,474 shares
- Price
- US$2.34 average (US$2.33 to US$2.37)
- Value
- US$350K
- Holding after
- 2,990,109 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Stock | Buy | 118,185 | US$2.34 | 2,958,820 | Indirect |
| Oct 19, 2026 | Common Stock | Buy | 12,790 | US$2.34 | 2,971,610 | Indirect |
| Oct 19, 2026 | Common Stock | Buy | 18,279 | US$2.33 | 2,989,889 | Indirect |
| Oct 20, 2026 | Common Stock | Buy | 220 | US$2.37 | 2,990,109 | Indirect |
Source
Download original · View original at SEC
Related
- Boundless Bio, Inc.
- Tang Kevin
- Boundless Bio, Inc. shareholders
- Form 4 · Tang Kevin · Jul 21, 2026
- Form 4 · Tang Kevin · Jul 16, 2026
- Form 4 · Tang Kevin · Jul 13, 2026
- Form 4 · Tang Kevin · Jul 8, 2026
- Form 4 · Tang Kevin · Jul 2, 2026
- Form 4 · Tang Capital Management LLC · Aug 28, 2026
- Schedule 13G · Zachary Hornby · Aug 27, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Form 4 · Gillis Steven · Jul 6, 2026